Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD

[1]  M. Thase,et al.  A history of childhood attention‐deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD , 2009, Acta psychiatrica Scandinavica.

[2]  A. Nordström,et al.  CSF 5-HIAA and DST non-suppression — Orthogonal biologic risk factors for suicide in male mood disorder inpatients , 2009, Psychiatry Research.

[3]  F. Poustka,et al.  Diminished 5‐HT functioning in CBCL pediatric bipolar disorder‐profiled ADHD patients versus normal ADHD: susceptibility to rapid tryptophan depletion influences reaction time performance , 2008, Human psychopharmacology.

[4]  L. Tamam,et al.  Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates , 2008, European Archives of Psychiatry and Clinical Neuroscience.

[5]  J. Krause,et al.  SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder , 2008, Expert review of neurotherapeutics.

[6]  A. Kummer,et al.  Dopamine and bipolar disorder , 2008, Acta psychiatrica Scandinavica.

[7]  J. Buitelaar,et al.  Reliability, Validity, and Utility of Instruments for Self-Report and Informant Report Concerning Symptoms of ADHD in Adult Patients , 2008, Journal of attention disorders.

[8]  F. Poustka,et al.  Serotonergic functioning and trait‐impulsivity in attention‐deficit/hyperactivity‐disordered boys (ADHD): influence of rapid tryptophan depletion , 2008, Human psychopharmacology.

[9]  S. Rauch,et al.  Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane , 2007, Biological Psychiatry.

[10]  M. Devoto,et al.  ADHD genetics: 2007 update , 2007, Current psychiatry reports.

[11]  M. Bourin,et al.  Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder , 2007, Acta psychiatrica Scandinavica. Supplementum.

[12]  M. Åsberg,et al.  Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding. , 2007, Ciba Foundation symposium.

[13]  G. Gerra,et al.  Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients , 2007, Journal of Neural Transmission.

[14]  S. Iversen,et al.  Dopamine: 50 years in perspective , 2007, Trends in Neurosciences.

[15]  S. Faraone,et al.  Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder , 2007, Expert review of neurotherapeutics.

[16]  B. J. Casey,et al.  Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis , 2007, Neuropsychology Review.

[17]  J. Mann,et al.  A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. , 2006, Bipolar disorders.

[18]  Lin He,et al.  Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). , 2006, Human molecular genetics.

[19]  R. Kessler,et al.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. , 2006, The American journal of psychiatry.

[20]  C. Gillberg,et al.  Psychiatric telephone interview with parents for screening of childhood autism - tics, attention-deficit hyperactivity disorder and other comorbidities (A-TAC): preliminary reliability and validity. , 2005, The British journal of psychiatry : the journal of mental science.

[21]  Poonam Soni,et al.  Emotional Dysregulation in Adult ADHD and Response to Atomoxetine , 2005, Biological Psychiatry.

[22]  A. Nierenberg,et al.  Clinical and Diagnostic Implications of Lifetime Attention-Deficit/Hyperactivity Disorder Comorbidity in Adults with Bipolar Disorder: Data from the First 1000 STEP-BD Participants , 2005, Biological Psychiatry.

[23]  Olga V. Demler,et al.  The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population , 2005, Psychological Medicine.

[24]  M. Thase,et al.  Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). , 2004, Bipolar disorders.

[25]  A. Arnsten,et al.  Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions , 2004, Biological Psychiatry.

[26]  F. Levy.  Synaptic Gating and ADHD: A Biological Theory of Comorbidity of ADHD and Anxiety , 2004, Neuropsychopharmacology.

[27]  D. Kupfer,et al.  Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) , 2003, Biological Psychiatry.

[28]  S. Faraone,et al.  The genetics of pediatric-onset bipolar disorder , 2003, Biological Psychiatry.

[29]  G. Sachs,et al.  Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. , 2000, The American journal of psychiatry.

[30]  K. Blennow,et al.  Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters Monoamine metabolites in 120 suicide attempters and 47 controls , 1999, European Neuropsychopharmacology.

[31]  S. Faraone,et al.  Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype , 1997, Psychological Medicine.

[32]  M. Åsberg,et al.  CSF 5-HIAA predicts suicide risk after attempted suicide. , 1994, Suicide & life-threatening behavior.

[33]  K. Davis,et al.  Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. , 1993, Archives of general psychiatry.

[34]  P. Wender,et al.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. , 1993, The American journal of psychiatry.

[35]  K. Blennow,et al.  Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age , 1993, European Neuropsychopharmacology.

[36]  M. Linnoila,et al.  CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. , 1990, The Journal of clinical psychiatry.

[37]  M. Åsberg,et al.  Biochemical aspects of suicidal behavior , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  F. Goodwin,et al.  Cerebrospinal fluid monoamine metabolite levels in male arsonists. , 1987, Archives of general psychiatry.

[39]  J. Nurnberger,et al.  Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients , 1985, Biological Psychiatry.

[40]  B. Shaywitz,et al.  CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls. , 1984, The American journal of psychiatry.

[41]  P. Wender,et al.  Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in adults with attention deficit disorder, residual type , 1984, Psychiatry Research.

[42]  M. Åsberg,et al.  Monoamine metabolites in CSF and suicidal behavior. , 1981, Archives of general psychiatry.

[43]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[44]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[45]  J. Korf,et al.  Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space , 1977, Psychopharmacology.

[46]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .